Journal Information
Vol. 162. Issue 10.
Pages 470-476 (May 2024)
Vol. 162. Issue 10.
Pages 470-476 (May 2024)
Original article
Impact of systemic therapies on SARS-CoV-2 antibody seroprevalence in patients with immune-mediated diseases
Impacto de las terapias sistémicas en la seroprevalencia de anticuerpos contra el SARS-CoV-2 en pacientes con enfermedades inmunomediadas
Liz Romero-Bogado, Martina Steiner, Israel John Thuissard Vasallo, Cristina Andreu Vázquez, Teresa Navío, Santiago Muñoz-Fernández, on behalf of the BIOlogical drug study group in COVID infection (BIOCOVID)
Article information
These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscribe
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail